Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rofecoxib vs Diclofenac for Post-Bunionectomy Pain
NCT00092378Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Sep 2003
- Primary completion
- Dec 2003
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of rofecoxib in postoperative pain (3 arms), sponsored by Merck & Co. Primary endpoint: Total Pain Relief over 8 hours. Started Sep 2003; status: completed.
02
Drugs
rofecoxib
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT00092378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00092378.